52W $5.93 – $21.68
OptimizeRx Corporation reported net revenue of $109.4 million for FY 2025, representing an 18.8% increase from $92.1 million in FY 2024.
Revenue breakdown: Life Science Companies (96.6%), Other Revenue (3.4%).
OptimizeRx Corporation reported net revenue of $109.4 million for FY 2025, representing an 18.8% increase from $92.1 million in FY 2024. The company achieved profitability with net income of $5.1 million, a significant improvement from a net loss of $20.1 million in the prior year. Gross profit increased to $73.6 million (67.3% gross margin) from $59.4 million (64.5% margin) in...
Revenue by Segment